Patents by Inventor Johannes Martinus Maria Bloemers

Johannes Martinus Maria Bloemers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DRUG DELIVERY SYSTEM
    Publication number: 20210290551
    Abstract: The invention relates to a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a second coating comprising a second active ingredient.
    Type: Application
    Filed: April 6, 2021
    Publication date: September 23, 2021
    Applicant: EB IP HYBRITABS B.V.
    Inventors: Johannes Martinus Maria Bloemers, Anko Cornelus Eissens, Henderik Willem Frijlink, Leonardus Gerardus Jozef De Leede
  • Drug delivery system
    Patent number: 10966933
    Abstract: The invention relates to a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a second coating comprising a second active ingredient.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: April 6, 2021
    Assignee: EB IP HYBRITABS B.V.
    Inventors: Johannes Martinus Maria Bloemers, Anko Cornelus Eissens, Henderik Willem Frijlink, Leonardus Gerardus Jozef De Leede
  • USE OF TESTOSTERONE AND A 5-HT1A AGONIST IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20190262359
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Application
    Filed: May 14, 2019
    Publication date: August 29, 2019
    Applicant: EB IP LYBRIDOS B.V.
    Inventors: Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS, Robertus Petrus Johannes DE LANGE
  • Use of testosterone and a 5-HT1A agonist in the treatment of sexual dysfunction
    Patent number: 10314848
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: June 11, 2019
    Assignee: EB IP LYBRIDOS B.V.
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
  • DRUG DELIVERY SYSTEM
    Publication number: 20170354605
    Abstract: The invention relates to a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a second coating comprising a second active ingredient.
    Type: Application
    Filed: August 25, 2017
    Publication date: December 14, 2017
    Applicant: EB IP HYBRITABS B.V.
    Inventors: Johannes Martinus Maria BLOEMERS, Anko Cornelus EISSENS, Henderik Willem FRIJLINK, Leonardus Gerardus Jozef DE LEEDE
  • Drug delivery system
    Patent number: 9763884
    Abstract: The invention relates to a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a second coating comprising a second active ingredient.
    Type: Grant
    Filed: May 14, 2012
    Date of Patent: September 19, 2017
    Assignee: EB IP HYBRITABS B.V.
    Inventors: Johannes Martinus Maria Bloemers, Anko Cornelus Eissens, Henderik Willem Frijlink, Leonardus Gerardus Jozef De Leede
  • Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
    Patent number: 9737548
    Abstract: The invention relates to the field of female sexual dysfunction. It specifically relates to the influence of the combination of testosterone or an analog thereof and tadalafil on sexual health in female subjects with Female Sexual Dysfunction (such as Female Sexual Arousal Disorder (FSAD) or Female Sexual Desire Disorder (FSDD)). It further relates to the influence of the combination of testosterone or an analog thereof and a compound capable of at least in part inhibiting smooth muscle constriction, for example a compound capable of at least in part inhibiting the adrenergic tone. The invention further discloses other combinatorial therapies in the treatment of Female Sexual Dysfunction.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: August 22, 2017
    Assignee: EB IP LYBRIDO B.V.
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers
  • USE OF TESTOSTERONE AND A 5-HT1A AGONIST IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20170157142
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Application
    Filed: February 21, 2017
    Publication date: June 8, 2017
    Applicant: EB IP LYBRIDOS B.V.
    Inventors: Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS, Robertus Petrus Johannes DE LANGE
  • Use of testosterone and a 5-HT1A agonist in the treatment of sexual dysfunction
    Patent number: 9597335
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Grant
    Filed: December 4, 2015
    Date of Patent: March 21, 2017
    Assignee: EB IP LYBRIDOS B.V.
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
  • PHARMACEUTICAL FORMULATIONS AND USES THEREOF IN THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
    Publication number: 20170042911
    Abstract: The invention relates to the field of female sexual dysfunction. It specifically relates to the influence of the combination of testosterone or an analog thereof and tadalafil on sexual health in female subjects with Female Sexual Dysfunction (such as Female Sexual Arousal Disorder (FSAD) or Female Sexual Desire Disorder (FSDD)). It further relates to the influence of the combination of testosterone or an analog thereof and a compound capable of at least in part inhibiting smooth muscle constriction, for example a compound capable of at least in part inhibiting the adrenergic tone. The invention further discloses other combinatorial therapies in the treatment of Female Sexual Dysfunction.
    Type: Application
    Filed: October 26, 2016
    Publication date: February 16, 2017
    Applicant: EB IP LYBRIDO B.V.
    Inventors: Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS
  • PHARMACEUTICAL FORMULATIONS AND USES THEREOF IN THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
    Publication number: 20160213683
    Abstract: The invention relates to the field of female sexual dysfunction. It specifically relates to the influence of the combination of testosterone or an analog thereof and tadalafil on sexual health in female subjects with Female Sexual Dysfunction (such as Female Sexual Arousal Disorder (FSAD) or Female Sexual Desire Disorder (FSDD)). It further relates to the influence of the combination of testosterone or an analog thereof and a compound capable of at least in part inhibiting smooth muscle constriction, for example a compound capable of at least in part inhibiting the adrenergic tone. The invention further discloses other combinatorial therapies in the treatment of Female Sexual Dysfunction.
    Type: Application
    Filed: April 1, 2016
    Publication date: July 28, 2016
    Applicant: EB IP LYBRIDO B.V.
    Inventors: Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS
  • USE OF TESTOSTERONE AND A 5-HT1A AGONIST IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20160082018
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Application
    Filed: December 4, 2015
    Publication date: March 24, 2016
    Applicant: EMOTIONAL BRAIN B.V.
    Inventors: Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS, Robertus Petrus Johannes DE LANGE
  • Use of testosterone and a 5-HT1A agonist in the treatment of sexual dysfunction
    Patent number: 9211334
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Grant
    Filed: October 8, 2013
    Date of Patent: December 15, 2015
    Assignee: EB IP LYBRIDOS B.V.
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
  • DRUG DELIVERY SYSTEM
    Publication number: 20150056277
    Abstract: The invention relates to a time controlled, immediate release drug delivery system for oral administration of a first active ingredient to a subject in need thereof. The invention additionally relates to a dual drug delivery device, comprising the time controlled, immediate release drug delivery system according to the invention, further comprising a second coating comprising a second active ingredient.
    Type: Application
    Filed: May 14, 2012
    Publication date: February 26, 2015
    Applicant: EMOTIONAL BRAIN B.V.
    Inventors: Johannes Martinus Maria Bloemers, Anko Cornelus Eissens, Henderik Willem Frijlink, Leonardus Gerardus Jozef De Leede
  • USE OF 3-ALPHA-ANDROSTANEDIOL, OPTIONALLY IN COMBINATION WITH A PDE5 INHIBITOR, IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20140121190
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of 3-alpha-androstanediol, preferably in combination with a type 5 phosphodiesterase (PDE5) inhibitor.
    Type: Application
    Filed: January 3, 2014
    Publication date: May 1, 2014
    Applicant: EMOTIONAL BRAIN B.V.
    Inventors: Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS, Robertus Petrus Johannes DE LANGE
  • USE OF 3-ALPHA-ANDROSTANEDIOL, OPTIONALLY IN COMBINATION WITH A 5-HT1A AGONIST, IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20140121189
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of 3-alpha-androstanediol, preferably in combination with a 5-HT1A agonist. Optionally, said 3-alpha-androstanediol and said 5HT1a agonist are further combined with a type 5 phosphodiesterase (PDE5) inhibitor.
    Type: Application
    Filed: January 3, 2014
    Publication date: May 1, 2014
    Applicant: EMOTIONAL BRAIN B.V.
    Inventors: Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS, Robertus Petrus Johannes DE LANGE
  • Use of testosterone and a 5-HT1A agonist in the treatment of sexual dysfunction
    Patent number: 8669242
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Grant
    Filed: July 10, 2012
    Date of Patent: March 11, 2014
    Assignee: Emotional Brain B.V.
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
  • Use of 3-alpha-androstanediol in combination with a PDE5 inhibitor, in the treatment of sexual dysfunction
    Patent number: 8653051
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of 3-alpha-androstanediol, preferably in combination with a type 5 phosphodiesterase (PDE5) inhibitor.
    Type: Grant
    Filed: November 2, 2007
    Date of Patent: February 18, 2014
    Assignee: Emotional Brain B.V.
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
  • Use of 3-alpha-androstanediol in combination with a 5-HT1a agonist, in the treatment of sexual dysfunction
    Patent number: 8648060
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of 3-alpha-androstanediol, preferably in combination with a 5-HT1A agonist. Optionally, said 3-alpha-androstanediol and said 5HT1a agonist are further combined with a type 5 phosphodiesterase (PDE5) inhibitor.
    Type: Grant
    Filed: November 2, 2007
    Date of Patent: February 11, 2014
    Assignee: Emotional Brain B.V.
    Inventors: Jan Johan Adriaan Tuiten, Johannes Martinus Maria Bloemers, Robertus Petrus Johannes De Lange
  • USE OF TESTOSTERONE AND A 5-HT1A AGONIST IN THE TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20140038929
    Abstract: The invention relates to the field of male and/or female sexual dysfunction. The invention specifically relates to the use of testosterone and a 5-HT1A agonist.
    Type: Application
    Filed: October 8, 2013
    Publication date: February 6, 2014
    Applicant: EMOTIONAL BRAIN B.V.
    Inventors: Jan Johan Adriaan TUITEN, Johannes Martinus Maria BLOEMERS, Robertus Petrus Johannes DE LANGE